financetom
Business
financetom
/
Business
/
Market Chatter: CoreWeave Doesn't Plan to Change its Bid for Core Scientific
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: CoreWeave Doesn't Plan to Change its Bid for Core Scientific
Oct 7, 2025 11:33 AM

02:10 PM EDT, 10/07/2025 (MT Newswires) -- CoreWeave ( CRWV ) doesn't plan to change its $9 billion bid for Core Scientific ( CORZ ) , Bloomberg reported Tuesday, citing CoreWeave ( CRWV ) chief executive officer Michael Intrator from an interview on Bloomberg Television.

Intrator's comments come after Core Scientific ( CORZ ) investor Two Seas Capital issued a letter last month to shareholders explaining its opposition to the deal under the planned terms, which include "an inadequate valuation, a deficient structure and a flawed process."

"Really under no circumstances will we readdress the bid that we put out," Intrator said, according to Bloomberg.

Shares of CoreWeave ( CRWV ) and Core Scientific ( CORZ ) were down 3.6% and 4.6% in recent Tuesday trading.

CoreWeave ( CRWV ) and Core Scientific ( CORZ ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 129.77, Change: -4.09, Percent Change: -3.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
E-commerce firm Aterian Q3 revenue falls
E-commerce firm Aterian Q3 revenue falls
Nov 13, 2025
Overview * Aterian Q3 2025 revenue declined yr/yr, missing analyst expectations * Reports Adjusted EBITDA loss, beating analyst estimates * Company expanded product offerings and sales channels to support future growth Outlook * Company reiterates net revenue guidance of $36 mln to $38 mln for H2 2025 * Company expects Adjusted EBITDA of $0 to a loss of $(1.0) mln...
Newsmax Q3 Net Loss Narrows, Revenue Increases
Newsmax Q3 Net Loss Narrows, Revenue Increases
Nov 13, 2025
04:32 PM EST, 11/13/2025 (MT Newswires) -- Newsmax ( NMAX ) reported a Q3 net loss late Thursday of $0.03 per diluted share, narrower than a loss of $0.29 a year earlier. One analyst expected a loss of $0.02 in a FactSet poll. Revenue for the quarter ended Sept. 30 was $45.3 million, up from $43.5 million a year earlier....
Trevi Therapeutics Q3 net loss narrows, cash runway extended into 2028
Trevi Therapeutics Q3 net loss narrows, cash runway extended into 2028
Nov 13, 2025
Overview * Trevi Therapeutics' ( TRVI ) Q3 net loss narrows to $11.8 mln from $13.2 mln in 2024 * Company preparing to initiate Phase 3 program for chronic cough in IPF in 2026 * Trevi ends Q3 with $194.9 mln in cash, runway expected into 2028 Outlook * Company plans to initiate Phase 3 program for chronic cough in...
StubHub Q3 Loss Widens, Revenue Rises
StubHub Q3 Loss Widens, Revenue Rises
Nov 13, 2025
04:32 PM EST, 11/13/2025 (MT Newswires) -- StubHub ( STUB ) reported a Q3 loss late Thursday of $4.27 per diluted share, widening from a loss of $0.15 a year earlier. Analysts polled by FactSet expected a loss of $2.87. Revenue for the three months ended Sept. 30 was $468.1 million, up from $433.8 million a year earlier. Analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved